PMID- 18294489 OWN - NLM STAT- MEDLINE DCOM- 20080313 LR - 20131121 IS - 1097-6744 (Electronic) IS - 0002-8703 (Linking) VI - 155 IP - 3 DP - 2008 Mar TI - Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke. PG - 515-20 LID - 10.1016/j.ahj.2007.10.032 [doi] AB - BACKGROUND: Patients with coronary heart disease (CHD) are at increased risk of stroke. We investigated in a large cohort of patients with CHD the relationship between functional status, as assessed by the New York Heart Association (NYHA) classification, and incident ischemic stroke. METHODS: We followed up 15,524 patients with documented CHD, screened for inclusion in a clinical trial (Bezafibrate Infarction Prevention), for 4.8 to 8.1 years. Functional status at baseline was categorized according to the NYHA classification. Among 14,703 patients, free of stroke, with recorded NYHA functional class, 1086 (7.4%) developed an ischemic cerebrovascular event, of whom 604 (4.1%) patients were confirmed to have an ischemic stroke or transient ischemic attack. RESULTS: The cumulative rate of ischemic cerebrovascular events increased from 6.7% in patients with NYHA functional class I to 9.2% and 9.7% for patients with NYHA functional classes II and III, respectively (P < .001). Adjustments were made in Cox proportional hazard models for age, sex, body mass index, past myocardial infarction, current smoking, diabetes, hypertension, peripheral vascular disease, percent of cholesterol in high-density lipoprotein, and triglyceride levels. The adjusted hazard ratios associated with NYHA functional class II and III were 1.29 (95% confidence interval 1.12-1.48) and 1.71 (95% confidence interval 1.36-2.15), respectively, as compared with patients with NYHA class I. CONCLUSIONS: Our findings indicate that stable coronary patients with even a slight limitation based on the NYHA functional class are exposed to an increased risk of ischemic stroke. FAU - Koren-Morag, Nira AU - Koren-Morag N AD - Division of Epidemiology, Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel. FAU - Goldbourt, Uri AU - Goldbourt U FAU - Tanne, David AU - Tanne D LA - eng PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial DEP - 20080131 PL - United States TA - Am Heart J JT - American heart journal JID - 0370465 RN - 0 (Hypolipidemic Agents) RN - Y9449Q51XH (Bezafibrate) SB - IM MH - Aged MH - Bezafibrate/*therapeutic use MH - Brain Ischemia/epidemiology/*etiology/prevention & control MH - Confidence Intervals MH - Coronary Disease/classification/*complications/drug therapy MH - Female MH - Follow-Up Studies MH - Heart Rate/*physiology MH - Humans MH - Hypolipidemic Agents/*therapeutic use MH - Incidence MH - Male MH - Middle Aged MH - Prognosis MH - Proportional Hazards Models MH - Retrospective Studies MH - Societies, Medical MH - Time Factors EDAT- 2008/02/26 09:00 MHDA- 2008/03/14 09:00 CRDT- 2008/02/26 09:00 PHST- 2007/04/11 00:00 [received] PHST- 2007/10/24 00:00 [accepted] PHST- 2008/02/26 09:00 [pubmed] PHST- 2008/03/14 09:00 [medline] PHST- 2008/02/26 09:00 [entrez] AID - S0002-8703(07)00865-4 [pii] AID - 10.1016/j.ahj.2007.10.032 [doi] PST - ppublish SO - Am Heart J. 2008 Mar;155(3):515-20. doi: 10.1016/j.ahj.2007.10.032. Epub 2008 Jan 31.